---
schema_version: "secwatch.filing_event.v1"
accession: "0001367644-22-000009"
form_type: "8-K"
ticker: "EBS"
cik: "0001367644"
company_name: "Emergent BioSolutions Inc."
filed_at: "2022-02-22T23:59:59+00:00"
generated_at: "2026-06-27T05:59:33.890920+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Emergent BioSolutions: Executive Chairman retiring Apr 1; bonuses at 75% of target; Saran, Fox promoted

## Summary
- Fuad El-Hibri to retire as Executive Chairman effective April 1, 2022; no 2022 equity grant.
- 2021 cash bonuses paid at ~75% of target due to below-target performance; CEO Kramer received $900,000.
- Atul Saran promoted to EVP, Chief Strategy and Development Officer effective March 1, 2022.
- Jennifer Fox promoted to EVP, External Affairs, General Counsel and Corporate Secretary effective March 1, 2022.
- One-time retention equity awards granted to NEOs (excluding El-Hibri); Kramer got $900K in PSUs.

## SEC filing metadata
- accession: 0001367644-22-000009
- form_type: 8-K
- ticker: EBS
- cik: 0001367644
- company_name: Emergent BioSolutions Inc.
- filed_at: 2022-02-22T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367644/000136764422000009/0001367644-22-000009-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367644/000136764422000009/ebs-20220215.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001367644-22-000009
- JSON: https://secwatch.observer/filing/0001367644-22-000009.json
- Plain text: https://secwatch.observer/filing/0001367644-22-000009.txt

## Key facts
- Executive change
  Fuad El-Hibri departed as Executive Chairman at Emergent BioSolutions Inc..
  - Action: retire
  - Role: Executive Chairman
  source text: The Executive Chairman, who has announced that he will retire from the Company effective April 1, 2022, will not receive an annual equity grant.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1367644/000136764422000009/0001367644-22-000009-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.